fashion -WSS

fashion

author：knowledge 2025-09-29 22:50:06 - browse：92

Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Why palliative psychiatry is worth discussing

WSS

Antivenom research: Lessons from HIV applied in search for universal antidote

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

At ASCO, AstraZeneca reports strong data for breast cancer drug

Innovation in antibiotics is ailing. 'Brain drain' may kill it

The Pandemic Treaty must support building strong health systems

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

hotspot

fashion

explore

New air purifier tech could be key to improving indoor air quality

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Medicare details structure of new drug price negotiation program

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Cancer drug shortages should be causing more outrage

Why palliative psychiatry is worth discussing

The high cost of giving birth even with insurance

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Psychedelics group wrestles with new pharma identity

FDA's Pazdur wants cancer trials to range beyond China alone

focus

The Pandemic Treaty must support building strong health systems

ASCO: Palliative care found as helpful given virtually as in person

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

With competition flaring, obesity drug hits goal in liver disease study

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

focus

entertainment

Wikipedia

knowledge